🇺🇸 FDA
Patent

US 9901638

Composition and method for treating an autoimmune disease

granted A61KA61K31/435A61K31/438

Quick answer

US patent 9901638 (Composition and method for treating an autoimmune disease) held by RedHill Biopharma Ltd. expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RedHill Biopharma Ltd.
Grant date
Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/435, A61K31/438, A61K31/498, A61K31/7048